UBS Group’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-21,000
Closed -$856K 8906
2020
Q3
$856K Buy
21,000
+5,000
+31% +$249K ﹤0.01% 3757
2020
Q2
$876K Sell
16,000
-107,200
-87% -$6.13M ﹤0.01% 3619
2020
Q1
$6.44M Buy
+123,200
New +$6.67M ﹤0.01% 1725

Other funds holding TRHC

UBS Group's TRHC Position: Q4 2023 in Review

UBS Group sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2023, closing a stake of 95,104 shares — an estimated $981K sold.

UBS Group first reported a position in TRHC in Q4 2016 and held it in 28 quarters. The position peaked at $7.26M in Q1 2023. 1 fund tracked by Wall St. Rank holds TRHC as of Q4 2023.

  • UBS Group reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • UBS Group sold 95,104 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2023, an estimated $981K.
  • UBS Group first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q4 2016 and held it in 28 quarters.
  • UBS Group's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $7.26M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.